Plan your trip to Osaka, Japan

Theme: Promulgating the prevention of adverse drug reaction

The conference offers richer experiences for Exhibitors, Sponsors, Plenary Sessions, keynote talks, Poster presentations, B2B meetings, and networking panels.
For Conference details, please visit: https://bit.ly/2HwRNwR

Benefits

·         Best platform to develop new partnership & collaborations.

·         Network development with both Academia and Business.

·         Recognition to your products and services in the world market through our website.

·         Shape and raise your corporate image through logo branding.

·         Special privileges on group registrations.

·         Develop new client relationships and strengthen the existing ones (B2B Meeting).

Participating Companies:

·         Abbvie,USA

·         E&Y, China

·         Salmanz Group, Australia

·         Nucleon Therapetics, India

·         Saudi Patient safety Center, Saudi

·         AlphaBeta Pharma, UK

·         King Abdullah Medical City (KAMC)

·         Takeda, USA

Please let me know your confirmation at the earliest convenience.

Best Regards   Zoey A Williams| Program Coordinator   Global Pharmacovigilance 2019   Ph: 4896666555 Ext:6028   Email:  globalpharmocovigilance2019@gmail.com

Mid Term Announcement of the conference- GPV 2019

Greetings of the day!!

We heartily welcome all the participants throughout the globe to participate in the conference titled 13th Global Pharmacovigilance and clinical trials summit. This event would be a great opportunity to gather knowledge as well as experience in the field of pharmacovigilance and clinical trials.

Session of the conference:

Pre-Clinical and Clinical Trials

Adverse Drug Reactions

Good Pharmacovigilance Practice

Drug Safety

Clinical Trial Protocols

Diversity in Industrial Clinical Trials and Clinical Research

Clinical Research and Statistics

Clinical Database Management

Medical and Clinical Case Reports

Hospital and Industrial Pharmacy

Clinical Data Management and Analytics

Clinical Trial Site Selection and Management

Medical and Clinical Case Reports

Biopharmaceutical Sciences

Our Confirmed Speakers:

Keynote:(Day 1)

Dr.Jacob Joseph, Harward Medical School, USA

Dr.Ujwala Salvi, Nucleon Therapeutics, India

Dr.Omer, Sanofi, Canada

Dr.Ashok, Clinfomatrix, USA

Other Speakers

Mr.Chi Chen, E&Y, China 

Dr.Meenal Patwardhan, Abbvie, USA

Mr.Rajiv Joshi, E&Y, India

Keynote (Day 2)

Dr.Essam, Celyad, Belgium

Dr.Carole, Sun Pharma, Japan

Mr.Robert, Accenture, Spain

Session Speakers:

Mr.Ravish Kumar, Salzman Group, Australia

Dr.Abdeen, Ministry of health, UK.

Dr.Ripal Gharia, Cliantha research, India

Mr.Mohammed Gayoor khan,NFPS,Malaysia

Participating Companies:

·         Abbvie,USA

·         E&Y, China

·         Salmanz Group, Australia

·         Nucleon Therapetics, India

·         Saudi Patient safety Center, Saudi

·         AlphaBeta Pharma, UK

·         King Abdullah Medical City (KAMC)

·         Takeda, USA